P91 Gemcitabine, epirubicin, and docetaxel (GED) asneoadjuvant therapy. Updated results from a multicenter phase II trial in locally advanced breast cancer

The Breast ◽  
2005 ◽  
Vol 14 ◽  
pp. S41
Author(s):  
D. Yardley ◽  
P. Whitworth ◽  
F. Greco ◽  
L. Dunbar ◽  
H. Burris ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document